Allscripts Healthcare Solutions (MDRX) to Release Quarterly Earnings on Thursday

Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) will announce its earnings results after the market closes on Thursday, May 5th. Analysts expect the company to announce earnings of $0.16 per share for the quarter. Allscripts Healthcare Solutions has set its FY 2022 guidance at EPS.Investors that wish to listen to the company’s conference call can do so using this link.

Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) last announced its earnings results on Thursday, February 24th. The software maker reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.47. The company had revenue of $391.70 million for the quarter, compared to analyst estimates of $390.63 million. Allscripts Healthcare Solutions had a return on equity of 10.91% and a net margin of 8.94%. The firm’s quarterly revenue was up 1.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.24 earnings per share. On average, analysts expect Allscripts Healthcare Solutions to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shares of NASDAQ MDRX opened at $21.27 on Thursday. The firm has a market cap of $2.61 billion, a price-to-earnings ratio of 21.06, a PEG ratio of 1.83 and a beta of 0.98. The company has a quick ratio of 1.39, a current ratio of 1.39 and a debt-to-equity ratio of 0.25. Allscripts Healthcare Solutions has a 52-week low of $13.05 and a 52-week high of $23.25. The business’s 50 day moving average is $21.67 and its two-hundred day moving average is $18.82.

In related news, CFO Richard J. Poulton sold 10,000 shares of the business’s stock in a transaction on Tuesday, February 15th. The shares were sold at an average price of $20.83, for a total transaction of $208,300.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Paul Black sold 60,000 shares of the business’s stock in a transaction on Thursday, March 10th. The stock was sold at an average price of $21.87, for a total transaction of $1,312,200.00. The disclosure for this sale can be found here. Insiders own 1.91% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MDRX. Janus Henderson Group PLC acquired a new position in Allscripts Healthcare Solutions in the third quarter valued at $213,000. Credit Suisse AG boosted its stake in Allscripts Healthcare Solutions by 35.9% in the fourth quarter. Credit Suisse AG now owns 172,209 shares of the software maker’s stock valued at $3,178,000 after acquiring an additional 45,508 shares in the last quarter. Parametric Portfolio Associates LLC boosted its stake in Allscripts Healthcare Solutions by 10.5% in the fourth quarter. Parametric Portfolio Associates LLC now owns 415,207 shares of the software maker’s stock valued at $7,661,000 after acquiring an additional 39,354 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in Allscripts Healthcare Solutions by 15.9% in the fourth quarter. Goldman Sachs Group Inc. now owns 3,427,095 shares of the software maker’s stock valued at $63,229,000 after acquiring an additional 469,894 shares in the last quarter. Finally, Vident Investment Advisory LLC boosted its stake in Allscripts Healthcare Solutions by 4.0% in the fourth quarter. Vident Investment Advisory LLC now owns 112,737 shares of the software maker’s stock valued at $2,080,000 after acquiring an additional 4,382 shares in the last quarter. Institutional investors own 96.40% of the company’s stock.

A number of analysts have issued reports on the company. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating and set a $23.00 target price on the stock. in a research report on Tuesday, March 29th. Piper Sandler boosted their target price on Allscripts Healthcare Solutions from $19.00 to $22.00 and gave the company a “neutral” rating in a research report on Friday, March 18th. TheStreet raised Allscripts Healthcare Solutions from a “c+” rating to a “b” rating in a research report on Friday, February 25th. SVB Leerink boosted their target price on Allscripts Healthcare Solutions from $22.00 to $24.00 and gave the company an “outperform” rating in a research report on Thursday, March 3rd. Finally, Deutsche Bank Aktiengesellschaft raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and upped their price objective for the stock from $20.00 to $26.00 in a research report on Friday, March 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $22.50.

About Allscripts Healthcare Solutions (Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Earnings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.